Van Dam et al.[14] already showed that with the use of fluorescence imaging using a folate receptor alpha targeting probe (that is over-expressed in 90–95% of ovarian cancer patients), it was possible to identify more tumor deposits than by the naked eye. Here, FOLR1 is linked to neoplasm.